The 29th Annual Meeting of Japan Society of Gene and Cell Therapy

Presentation information

Print

Presidential Special Program

[SP1] Presidential Special Program 1

Tue. Sep 12, 2023 3:00 PM - 4:30 PM Room 1 (1001-1003, 10Ｆ, OICC)

Chairs:Yasushi Kajii（R&D Japan Region, Takeda Pharmaceutical Company Limited）,Yasuko Terao（Janssen Pharmaceutical Company, Global Government Grant Office）

[SP1-1] Gene therapy technologies to be expected by global pharma in the future

○Yasushi Kajii1 (1.Takeda Pharmaceutical Company Limited, 2.Waseda University)

Keywords:Neuropsychopharmacology, Molecular and cognitive neuroscience, Stem cell science

photo
Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry
Mitsubishi Tanabe Pharma Corporation
AbbVie GK
Novartis Pharma K.K.
Takeda Pharmaceutical Company Limited

Abstract password authentication.
The password was sent to all registrants in email.

Password